Summary of gene mutations in patients (pt) with ibrutinib (ibr)-relapsed disease. Four studies published to date were summarized. Number of patients in each category is indicated. *Neither BTK nor PLCG2 mutation. **One patient with RT had both BTK and PLCG2 mutations. PD, progressive disease.